OCD Trial, Recruiting NCT06717165 Sponsor: Shanghai Mental Health Center Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT06717165
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 60 years old
  • You have completed at least 9 years of education
  • You have been diagnosed with OCD using a standard clinical interview called the MINI
  • Your OCD symptoms are at a moderate level or above, based on a standard OCD rating scale (called the Y-BOCS, with a score of 16 or higher)
  • You are either not taking any medication, or you have been on the same stable medication for at least 8 weeks before joining and are willing to keep taking the same medication throughout the study
  • Having anxiety or mild to moderate depression related to your OCD does not automatically disqualify you

Who may not be able to join:

  • You have a serious medical condition, neurological illness, or another psychiatric disorder besides OCD
  • Your OCD symptoms are so severe that completing the required assessments and examinations would not be possible
  • You are considered to be at serious risk of suicide
  • You are pregnant or planning to become pregnant
  • You are currently taking anti-seizure (antiepileptic) medication
  • You have significant physical health problems or abnormal results on medical tests that are considered clinically important (confirm with trial site)
  • You have already completed a full course of a talking therapy called CBT or ERP (a specific type of therapy focused on facing fears and resisting compulsions)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zhen Wang, PhD, MD, Shanghai Mental Health Center

Phone: +86 34773516

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Mental Health Center
Registry
ClinicalTrials.gov
Start date
15 April 2024
Est. completion
30 October 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

To explore the differences in treatment efficacy between active and sham transcranial alternating current stimulation (tACS) concurrent with exposure and response prevention (ERP)(tACS+ERP) in patients with obsessive-compulsive disorder (OCD).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov